Open access · CC-BY
via OpenAlex
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Zachary D. Wallen, Mary Appah, Marissa Dean, Cheryl L. Sesler, Stewart A. Factor, Eric Molho, Cyrus P. Zabetian, David G. Standaert, Haydeh Payami
npj Parkinson s Disease · 2020 · ▲ 240 citations
Abstract
Abstract In Parkinson’s disease (PD), gastrointestinal features are common and often precede the motor signs. Braak and colleagues proposed that PD may start in the gut, triggered by a pathogen, and spread to the brain. Numerous studies have examined the gut microbiome in PD; all found it to be altered, but found inconsistent results on associated microorganisms. Studies to date have been small ( N = 20 to 306) and are difficult to compare or combine due to varied methodology. We conducted a microbiome-wide association study (MWAS) with two large datasets for internal replication ( N = 333 and 507). We used uniform methodology when possible, interrogated confounders, and applied two statistical tests for concordance, followed by correlation network analysis to infer interactions. Fifteen genera were associated with PD at a microbiome-wide significance level, in both datasets, with both methods, with or without covariate adjustment. The associations were not independent, rather they represented three clusters of co-occurring microorganisms. Cluster 1 was composed of opportunistic pathogens and all were elevated in PD. Cluster 2 was short-chain fatty acid (SCFA)-producing bacteria and all were reduced in PD. Cluster 3 was carbohydrate-metabolizing probiotics and were elevated in PD. Depletion of anti-inflammatory SCFA-producing bacteria and elevated levels of probiotics are confirmatory. Overabundance of opportunistic pathogens is an original finding and their identity provides a lead to experimentally test their role in PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41531-020-0112-6
- Canonical
- link ↗
- Fetched
- 2026-06-12 MST
Cite this
APA
Wallen, Z.D., Appah, M., Dean, M., Sesler, C.L., Factor, S.A., Molho, E., Zabetian, C.P., Standaert, D.G., & Payami, H. (2020). Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. <em>npj Parkinson s Disease</em>. https://doi.org/10.1038/s41531-020-0112-6
Vancouver
Wallen ZD, Appah M, Dean M, Sesler CL, Factor SA, Molho E, et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. npj Parkinson s Disease. 2020. doi:10.1038/s41531-020-0112-6.
BibTeX
@article{zachary2020Charac,
title = {Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens},
author = {Zachary D. Wallen and Mary Appah and Marissa Dean and Cheryl L. Sesler and Stewart A. Factor and Eric Molho and Cyrus P. Zabetian and David G. Standaert and Haydeh Payami},
journal = {npj Parkinson s Disease},
year = {2020},
doi = {10.1038/s41531-020-0112-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Movement Disorders 2017
Citation only
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome
British Journal Of Nutrition 2014
Open access · CC-BY
Dietary effects on human gut microbiome diversity
British Journal of Pharmacology 2013
Open access · OA
First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics
Clinical Chemistry and Laboratory Medicine (CCLM) 2018
Open access · OA
Telomere biology and age-related diseases
Genome biology 2017
Open access · CC-BY
Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment
Philosophical Transactions of the Royal Society B Biological Sciences 2018
Open access · OA